Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome46
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program44
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction42
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making41
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis32
Right ventricular failure: a comorbidity or a clinical emergency?31
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Can mechanical circulatory support be an effective treatment for HFpEF patients?28
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction27
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris25
The role of TAVR in patients with heart failure: do we have the responses to all questions?25
Correction to: Is it time to revisit ICD indications?25
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?24
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition24
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution22
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review22
Clinical management of amyloid cardiomyopathy21
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?21
Filamin C in cardiomyopathy: from physiological roles to DNA variants20
Speckle tracking echocardiography in heart failure development and progression in patients with apneas19
Resistance training in heart failure patients: a systematic review and meta-analysis19
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers18
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease17
Advanced airway management and respiratory care in decompensated pulmonary hypertension17
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond16
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study15
Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”14
Letter to the Editor13
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure13
Left ventricular assist device in cardiac amyloidosis: friend or foe?13
Targeting mitochondrial dysfunction with elamipretide13
Experimental heart failure models in small animals12
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era12
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202111
Echocardiographic assessment of cardiac amyloidosis11
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review11
New onset nonischemic cardiomyopathy post liver transplantation10
Large animal models of heart failure with preserved ejection fraction10
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy10
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials9
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy9
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature8
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools8
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure8
0.031741142272949